The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Size Is Forecasted For The Buccal Drug Delivery System Market By 2030 Based On Its 2026 Value?
The buccal drug delivery system market has experienced swift expansion recently. It is projected to grow from $3.89 billion in 2025 to $4.32 billion in 2026, progressing at a compound annual growth rate (CAGR) of 11.2%. This historical growth is attributable to an increased preference for alternative drug delivery methods, the expansion of chronic pain and angina treatments, advancements in mucoadhesive formulations, a rising need for medications with a faster onset, and the broadening of oral pharmaceutical manufacturing.
The buccal drug delivery system market is anticipated to experience substantial growth in the upcoming years, expanding to $6.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected increase is driven by heightened investments in transmucosal drug research, a rising demand for smoking cessation therapies, the expansion of personalized drug delivery systems, a growing focus on compliance-friendly formulations, and the increasing development of novel buccal drugs. Key trends expected in this forecast period include the increasing adoption of buccal and sublingual dosage forms, a rising demand for rapid drug absorption systems, an increased focus on patient-friendly drug delivery, the expansion of controlled-release buccal formulations, and an enhanced emphasis on non-invasive therapies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
What Primary Factors Are Fueling The Expansion Of The Buccal Drug Delivery System Market?
The increasing occurrence of chronic diseases is expected to propel the growth of the buccal drug delivery systems market going forward. These conditions persist for a year or longer, encompassing ailments such as cancer, heart disease, stroke, diabetes, and arthritis. Such common long-term illnesses are manageable rather than curable, necessitating continuous medical care and nutritional support. Buccal drug delivery systems offer suitable and efficient methods for administering mucosal and transmucosal drugs, which are essential for many patients with chronic conditions like diabetes and cancer. For instance, the National Health Service, a UK-based government department, reported in June 2024 that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This marked an 18% increase from 3,065,825 cases in 2022. Consequently, the expanding prevalence of chronic diseases is a key factor driving the buccal drug delivery systems market.
What Are The Major Segment Categories Within The Buccal Drug Delivery System Market?
The buccal drug delivery system market covered in this report is segmented –
1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Subsegments:
1) By Sublingual: Sublingual Tablets, Sublingual Films
2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges
3) By Oral Sprays: Spray Solutions, Spray Gels
What Trends Are Influencing The Future Of The Buccal Drug Delivery System Market?
Companies operating significantly within the buccal drug delivery systems market are concentrating on introducing new products, such as melatonin oral spray, to enhance their market revenues. Melatonin oral spray is a form of melatonin supplement presented in a spray format for oral application. For example, in February 2023, Arlak Biotech Private Limited, an India-based pharmaceutical company, introduced a melatonin oral spray. This spray supports the body’s inherent melatonin production, thus improving sleep quality in a straightforward and efficient manner. This remedy offers a rapid solution for individuals who struggle with initiating sleep, maintaining sleep, or adapting to various sleep schedules. The spray’s swift and easy oral absorption contributes to a quicker onset of sleep and superior sleep quality.
Who Are The Leading Firms Participating In The Buccal Drug Delivery System Market?
Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd, Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd, AstraZeneca PLC, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc, NAPP Pharmaceutical Ltd, Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc, Par Pharmaceutical Companies Inc, Acorda Therapeutics Inc, Opiant Pharmaceuticals Inc
Access The Complete Buccal Drug Delivery System Market Report:
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
Which Regional Market Leads The Buccal Drug Delivery System Market?
North America was the largest region in the buccal drug delivery systems market share in 2025. The regions covered in the buccal drug delivery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Buccal Drug Delivery System Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=8290&type=smp
Browse Through More Reports Similar to the Global Buccal Drug Delivery System Market 2026, By The Business Research Company
Gastroretentive Drug Delivery Systems Outsourcing Market Report 2026
Pharmaceutical Drug Delivery Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Advanced Drug Delivery Systems Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model